A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies
Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the possibility that use of two similar but distinct
drugs used together in treatment of advanced cancer might prove less toxic than either agent
used alone, because dosages can be reduced for each agent. This is a phase I study that is
designed to measure the frequency and levels of specific side effects when Carboplatin and
Pazopanib are used in combination in advanced cancer patients. The possibility that
anti-tumor activity will occur is also going to be investigated.